4//SEC Filing
Friedman Bart 4
Accession 0001209191-22-024198
CIK 0001636651other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 5:53 PM ET
Size
5.5 KB
Accession
0001209191-22-024198
Insider Transaction Report
Form 4
Friedman Bart
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-04-08+69,424→ 69,424 totalExercise: $3.22Exp: 2032-04-07→ Common Stock (69,424 underlying)
Footnotes (1)
- [F1]The option shall vest as follows: 25% of the shares subject to the option will vest and become exercisable October 8, 2022 and the remaining shares will vest in 18 equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
Documents
Issuer
Ovid Therapeutics Inc.
CIK 0001636651
Entity typeother
Related Parties
1- filerCIK 0001368324
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 5:53 PM ET
- Size
- 5.5 KB